Advance your academic career, collaborate globally, and expand your network— join now !

Dr. Diego F. Calvisi

Università degli Studi di Sassari, Sassari, Italy

Share Link

Share

Information

Diego F Calvisi received his Medical Doctor and Clinical Pathologist degrees from the Medical School of the University of Sassari (Sassari, Italy). Afterward, he joined the Laboratory of Experimental Carcinogenesis, directed by Dr. Snorri S. Thorgeirsson at the National Cancer Institute (Bethesda, MD, USA). Subsequently, he established his laboratory at the Medical School of the University of Greifswald (Greifswald, Germany). Currently, he is a Professor of Experimental Tumor Pathology at the University of Regensburg (Regensburg, Germany), and an Associate Professor of General Pathology at the University of Sassari. He is also the Associate Editor of Carcinogenesis and Seminars in Liver Disease. He is also a reviewer for several journals and official agencies in Europe. He authored more than 200 publications in peer-reviewed journals to date. His scientific interest centers on liver cancer, specifically on mouse models of hepatocarcinogenesis,  the molecular pathogenesis of hepatobiliary tumors, and innovative therapies targeting signaling pathways and cancer metabolism.

Research Keywords & Expertise

Cancer Biology
Cancer Research
Cell Biology
Cell Culture
Cell Signaling

Short Biography

Diego F Calvisi received his Medical Doctor and Clinical Pathologist degrees from the Medical School of the University of Sassari (Sassari, Italy). Afterward, he joined the Laboratory of Experimental Carcinogenesis, directed by Dr. Snorri S. Thorgeirsson at the National Cancer Institute (Bethesda, MD, USA). Subsequently, he established his laboratory at the Medical School of the University of Greifswald (Greifswald, Germany). Currently, he is a Professor of Experimental Tumor Pathology at the University of Regensburg (Regensburg, Germany), and an Associate Professor of General Pathology at the University of Sassari. He is also the Associate Editor of Carcinogenesis and Seminars in Liver Disease. He is also a reviewer for several journals and official agencies in Europe. He authored more than 200 publications in peer-reviewed journals to date. His scientific interest centers on liver cancer, specifically on mouse models of hepatocarcinogenesis,  the molecular pathogenesis of hepatobiliary tumors, and innovative therapies targeting signaling pathways and cancer metabolism.